MENU
PTGX
AS OF
Nov 13 closing price
Price
$83.24
Change
-$1.61 (-1.90%)
Capitalization
5.2B
124 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
PTGX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Protagonist Therapeutics (PTGX) Earnings Date & Reports

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

PTGX is expected to report earnings to fall 34.84% to -40 cents per share on March 18

Protagonist Therapeutics PTGX Stock Earnings Reports
Q4'25
Est.
$-0.40
Q3'25
Beat
by $0.01
Q2'25
Beat
by $0.03
Q1'25
Missed
by $0.12
Q4'24
Beat
by $1.79
The last earnings report on November 06 showed earnings per share of -62 cents, beating the estimate of -62 cents. With 711.77K shares outstanding, the current market capitalization sits at 5.20B.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Choppy Market Trader for Beginners: Hi-tech Stocks (TA&FA)
60minChoppy Market Trader for Beginners: Hi-tech Stocks (TA&FA)
60min
Annualized Return+87%
VIEW DETAILSVIEW DETAILS
VIEW FOR FREEVIEW FOR FREE
PTGX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. PTGX showed earnings on November 06, 2025. You can read more about the earnings report here.
View AI-Driven Trading for PTGX
A.I. Advisor
published General Information

General Information

a developer of disulfide-rich peptides

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
7707 Gateway Boulevard
Phone
+1 510 474-0170
Employees
112
Web
https://www.protagonist-inc.com